is there an fda approved oral glp 1 Wegovy Pill Becomes First GLP-1 Weight-Loss Drug in U.S FDA Approves Oral Semaglutide: First

Small handful of nuts as snack

doi: 10.3389/fmed.2021.735150

Dubbed a triple agonist , Retatrutide is showing powerful resultsand its not just for weight loss

Retatrutide is a triple agonist, targeting the receptors of 3 hormones that can impact appetite, weight, and blood sugar levels, earning it the nicknames the triple-G and the Godzilla of weight loss jabs

Their work is a testament to the transformative power of innovative scientific discovery and the potential of these discoveries in shaping treatment methods and healthcare solutions.

It can reduce the risk of a stroke, heart attack, or death in adults who have type 2 diabetes along with heart and blood vessel disease, according to Medline Plus